Is there an Indian generic version of Gefitinib?

Gefitinib is mainly used to treat non-small cell lung cancer with EGFR gene mutations. EGFRmutations are more common in some patients, so gefitinib is often used for advanced or metastatic non-small cell lung cancer, especially when traditional chemotherapy methods are ineffective or inappropriate.

Gefitinib is available in Indian generics. In addition to Indian generics, there are also Bangladeshi and Lao generics. Generic drugs include generic drugs from India, Bangladesh and Laos, with different specifications and different prices, about200~800yuan, and the ingredients of generic drugs are basically the same as domestic drugs.

Gefitinib was launched in China in 2005. At that time, the price of a box was about 5,000 yuan. In 2017 it entered the domestic medical insurance. After the medical insurance, the price dropped a lot. There are domestically produced drugs in the country. For the specific price after the medical insurance, please consult the local hospital pharmacy or the medical insurance bureau.

Gefitinib is available as an oral tablet. Dosage is usually determined by a doctor based on the patient's condition, genetic mutation, and overall health. Patients need to take their medications exactly as recommended by their doctor and have regular follow-up visits.

Side effects of gefitinib may include skin reactions (such as rash, itching, dryness), gastrointestinal discomfort (such as nausea, vomiting, diarrhea), fatigue, abnormal liver function, etc. During use, patients should maintain close contact with their doctors and promptly report any discomfort or side effects.

During the period of using gefitinib, patients usually need to receive regular follow-up and monitoring by their doctors to evaluate the efficacy and safety of the drug. Your doctor may order genetic testing to determine if you are a candidate for gefitinib.